首页> 外文期刊>World Journal of Gastroenterology >Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice
【24h】

Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice

机译:益生菌补充剂对微生物群的修饰减少了小鼠结肠炎相关的结肠癌

获取原文

摘要

AIM To investigate the effect of probiotic supplementation during the development of an experimental model of colitis associated colon cancer (CAC). METHODS C57BL/6 mice received an intraperitoneal injection of azoxymethane (10 mg/kg), followed by three cycles of sodium dextran sulphate diluted in water (5% w/v). Probiotic group received daily a mixture of Lactobacillus acidophilus , Lactobacillus rhamnosus and Bifidobacterium bifidum . Microbiota composition was assessed by 16S rRNA Illumina HiSeq sequencing. Colon samples were collected for histological analysis. Tumor cytokines was assessed by Real Time-PCR (Polymerase Chain Reaction); and serum cytokines by Multiplex assay. All tests were two-sided. The level of significance was set at P < 0.05. Graphs were generated and statistical analysis performed using the software GraphPad Prism 5.0. The project was approved by the institutional review board committee. RESULTS At day 60 after azoxymethane injection, the mean number of tumours in the probiotic group was 40% lower than that in the control group, and the probiotic group exhibited tumours of smaller size (< 2 mm) ( P < 0.05). There was no difference in richness and diversity between groups. However, there was a significant difference in beta diversity in the multidimensional scaling analysis. The abundance of the genera Lactobacillus , Bifidobacterium , Allobaculum , Clostridium XI and Clostridium XVIII increased in the probiotic group ( P < 0.05). The microbial change was accompanied by reduced colitis, demonstrated by a 46% reduction in the colon inflammatory index; reduced expression of the serum chemokines RANTES and Eotaxin; decreased p-IKK and TNF-α and increased IL-10 expression in the colon. CONCLUSION Our results suggest a potential chemopreventive effect of probiotic on CAC. Probiotic supplementation changes microbiota structure and regulates the inflammatory response, reducing colitis and preventing CAC.
机译:目的研究益生菌补充剂在结肠炎相关结肠癌(CAC)实验模型开发过程中的作用。方法C57BL / 6小鼠腹膜内注射乙氧基甲烷(10 mg / kg),然后进行三个周期的用水稀释(5%w / v)的右旋糖酐硫酸钠。益生菌组每天接受嗜酸乳杆菌,鼠李糖乳杆菌和双歧双歧杆菌的混合物。通过16S rRNA Illumina HiSeq测序评估微生物群组成。收集结肠样品用于组织学分析。通过实时PCR(聚合酶链反应)评估肿瘤细胞因子。多重分析检测血清和血清细胞因子。所有测试都是双面的。显着性水平设定为P <0.05。使用软件GraphPad Prism 5.0生成图形并进行统计分析。该项目已获得机构审查委员会的批准。结果在注射甲氧甲烷后第60天,益生菌组的平均肿瘤数目比对照组低40%,而益生菌组的肿瘤较小(<2 mm)(P <0.05)。群体之间的丰富性和多样性没有差异。但是,多维缩放分析中的β多样性存在显着差异。益生菌组乳杆菌属,双歧杆菌属,同种菌属,梭状芽孢杆菌XI和梭状芽孢杆菌XVIII的丰度增加(P <0.05)。微生物改变伴有结肠炎减少,结肠炎指数降低46%证明了这一点。降低血清趋化因子RANTES和Eotaxin的表达;降低结肠中p-IKK和TNF-α并增加IL-10表达。结论我们的结果表明益生菌对CAC具有潜在的化学预防作用。益生菌补充剂可改变微生物群结构并调节炎症反应,减少结肠炎并预防CAC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号